We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$509M
AUM Growth
+$26M
(+5.4%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-9.03%
Top 10 Holdings %
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASRT
Assertio
ASRT
|
+$3.68M |
| 2 |
Red Robin
RRGB
|
+$3.46M |
| 3 |
Intapp
INTA
|
+$3.34M |
| 4 |
O-I Glass
OI
|
+$3.16M |
| 5 |
PDF Solutions
PDFS
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$4.8M |
| 2 |
Target Hospitality
TH
|
+$4.6M |
| 3 |
PDS Biotechnology
PDSB
|
+$4.36M |
| 4 |
Digi International
DGII
|
+$4.3M |
| 5 |
KLX Energy Services
KLXE
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25% |
| 2 | Technology | 21.39% |
| 3 | Industrials | 20.38% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Energy | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Dick's Sporting Goods
DKS
$18.7B
| $1.5M | 0.29% |
10,542
+1,191
| +13% | +$159K |
|
177
Sera Prognostics
SERA
$81.8M
| $1.48M | 0.29% |
+387,193
| New | +$1.02M |
|
178
Tiptree Inc
TIPT
$674M
| $1.47M | 0.29% |
100,668
| – | – |
|
179
Hyster-Yale Materials Handling
HY
$660M
| $1.46M | 0.29% |
+29,177
| New | +$1.07M |
|
180
Harvard Bioscience
HBIO
$29.1M
| $1.45M | 0.29% |
+34,555
| New | +$1.03M |
|
181
Asbury Automotive
ABG
$3.84B
| $1.42M | 0.28% |
+6,762
| New | +$1.43M |
|
182
AutoNation
AN
$6.92B
| $1.4M | 0.28% |
+10,448
| New | +$1.34M |
|
183
Park Aerospace
PKE
$817M
| $1.4M | 0.27% |
+103,815
| New | +$1.46M |
|
184
WillScot Mobile Mini Holdings
WSC
$4.41B
| $1.39M | 0.27% |
29,623
-693
| -2% | -$33.4K |
|
|
HYPD
185
Hyperion DeFi Inc
HYPD
$41.1M
| $1.39M | 0.27% |
+4,912
| New | +$1.04M |
|
186
Crawford & Co Class A
CRD.A
$667M
| $1.37M | 0.27% |
+163,833
| New | +$1.07M |
|
187
Verrica Pharmaceuticals
VRCA
$89M
| $1.36M | 0.27% |
+20,907
| New | +$1.26M |
|
188
Silgan Holdings
SLGN
$4.41B
| $1.35M | 0.26% |
25,104
-2,421
| -9% | -$128K |
|
|
ITI
189
DELISTED
Iteris, Inc.
ITI
| $1.34M | 0.26% |
+286,455
| New | +$1.2M |
|
190
Timken Company
TKR
$9.03B
| $1.33M | 0.26% |
+16,312
| New | +$1.32M |
|
191
ThredUp
TDUP
$422M
| $1.3M | 0.26% |
+513,981
| New | +$958K |
|
192
Noble Corp
NE
$6.51B
| $1.3M | 0.26% |
32,891
-2,211
| -6% | -$88.5K |
|
|
IVAC
193
DELISTED
Intevac Inc
IVAC
| $1.3M | 0.25% |
+177,020
| New | +$1.24M |
|
194
J. Jill
JILL
$281M
| $1.29M | 0.25% |
49,414
-20,001
| -29% | -$529K |
|
195
Concrete Pumping Holdings
BBCP
$489M
| $1.28M | 0.25% |
+187,814
| New | +$1.37M |
|
|
CHUY
196
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.27M | 0.25% |
35,513
| – | – |
|
197
Clean Harbors
CLH
$16.3B
| $1.27M | 0.25% |
8,921
-958
| -10% | -$125K |
|
198
Perion Network
PERI
$387M
| $1.26M | 0.25% |
+31,960
| New | +$1.06M |
|
199
Orion
OEC
$409M
| $1.26M | 0.25% |
+48,376
| New | +$1.09M |
|
200
RenaissanceRe
RNR
$13.4B
| $1.25M | 0.25% |
6,258
-1,517
| -20% | -$305K |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q1 2023 Portfolio in Review
As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.
- EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
- EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
- EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
- EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
- EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
- EAM Investors opened 139 new positions and closed 144 in Q1 2023.
- EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.
Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.